Not applicableStudy completedNCT05557955What this trial is testingIdentification of Breath Biomarkers in Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Mian XI 210
Testing effectiveness (Phase 2)Looking for participantsNCT06869213What this trial is testingA Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous CarcinomaWho this might be right forEsophageal Cancer (EsC) Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT03251417What this trial is testingApatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Peking University 11
Not applicableActive Not RecruitingNCT06828718What this trial is testingThe Neoadjuvant Treatment Modalities in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma (NEO-EC）Who this might be right forEsophageal Carcinoma Hebei Medical University Fourth Hospital 1,000
Large-scale testing (Phase 3)UnknownNCT02461043What this trial is testingAdjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Cancer Chinese Academy of Medical Sciences 386
Not applicableStudy completedNCT01551589What this trial is testingInvolved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Chengya Chou 220
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678580What this trial is testingNeoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma (ESCC) Tang-Du Hospital 50
Not applicableUnknownNCT04229524What this trial is testingQuantitative Assessment of Blood Supply in the Gastic Conduit With Fluorescence Angiography for Esophageal ReconstructionWho this might be right forEsophageal Squamous Cell Carcinoma Sichuan Cancer Hospital and Research Institute 246
Early research (Phase 1)Ended earlyNCT04060342What this trial is testingGB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableUnknownNCT00766480What this trial is testingStudy of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagusWho this might be right forEsophageal Cancer University of Toyama 160
Testing effectiveness (Phase 2)UnknownNCT05596890What this trial is testingPatient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer PatientsWho this might be right forEsophageal Squamous Cell CarcinomaPatient-reported OutcomesImmunotherapy Guangdong Provincial People's Hospital 50
Not applicableStudy completedNCT03081715What this trial is testingPD-1 Knockout Engineered T Cells for Advanced Esophageal CancerWho this might be right forEsophageal Cancer Hangzhou Cancer Hospital 16
Early research (Phase 1)Ended earlyNCT04116320What this trial is testingFocused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsWho this might be right forMelanomaBreast CancerMerkel Cell Carcinoma+10 more Craig L Slingluff, Jr 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693What this trial is testingA Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma The First Affiliated Hospital of Zhengzhou University 60
Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT03660449What this trial is testingModerately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Sun Yat-sen University 58
Early research (Phase 1)Ended earlyNCT06034860What this trial is testingStudy of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesWho this might be right forNon Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more Molecular Templates, Inc. 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062What this trial is testingSYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.Who this might be right forEsophageal Squamous Cell Carcinoma CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Testing effectiveness (Phase 2)Study completedNCT02350517What this trial is testingEndostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Yuhong Li 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798